← Product Code [JWH](/submissions/OR/subpart-d%E2%80%94prosthetic-devices/JWH) · K961021

# KIRSCHNER KNEE MODIFIED (K961021)

_Biomet, Inc. · JWH · Mar 17, 1997 · Orthopedic · SN_

**Canonical URL:** https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/JWH/K961021

## Device Facts

- **Applicant:** Biomet, Inc.
- **Product Code:** [JWH](/submissions/OR/subpart-d%E2%80%94prosthetic-devices/JWH.md)
- **Decision Date:** Mar 17, 1997
- **Decision:** SN
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 888.3560
- **Device Class:** Class 2
- **Review Panel:** Orthopedic
- **Attributes:** Therapeutic

## Intended Use

Total knee replacement is indicated for patients suffering from severe knee pain and disability. Specific indications include femoral, tibial and patellar replacement in a wide size range of patients who require implantation due to degenerative bone disease such as rheumatoid arthritis or osteoarthritis, primary and secondary traumatic arthritis, polyarthritis, collagen disorders, avascular necrosis of the femoral condyle, pseudo-gout or complications from a failed prosthesis.

## Device Story

Kirschner Knee Modified system comprises modular knee arthroplasty components (Performance, TC-IV, HybridFit systems). Inputs: surgical site anatomy. Operation: cemented implantation of cobalt-chromium femoral components, titanium tibial components, and UHMWPE patellar/bearing inserts. Features plasma-sprayed titanium alloy porous coating and ArCom UHMWPE. Used in orthopedic surgery by surgeons to replace diseased knee joints. Output: restored joint function and pain relief. Benefits: improved range of motion, size interchangeability, and bone fixation via modular augmentations and porous coating.

## Clinical Evidence

Bench testing only. No clinical data provided. Integrity of plasma spray coating and ArCom UHMWPE performance supported by historical data from previously cleared Biomet joint prostheses.

## Technological Characteristics

Materials: Cobalt-chromium alloy, titanium alloy, ArCom UHMWPE. Features: Plasma-sprayed titanium alloy porous coating, modular femoral/tibial components, fixation pegs, screw-hole tibial trays. Energy source: None (mechanical). Sterilization: Not specified. Connectivity: None.

## Regulatory Identification

A knee joint patellofemorotibial polymer/metal/polymer semi-constrained cemented prosthesis is a device intended to be implanted to replace a knee joint. The device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. This generic type of device includes prostheses that have a femoral component made of alloys, such as cobalt-chromium-molybdenum, and a tibial component or components and a retropatellar resurfacing component made of ultra-high molecular weight polyethylene. This generic type of device is limited to those prostheses intended for use with bone cement (§ 888.3027).

## Predicate Devices

- Maxim Total Knee System ([K915132](/device/K915132.md))
- AGC 2000 Total Knee Prosthesis ([K833921](/device/K833921.md))

## Submission Summary (Full Text)

> This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com.
>
> Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/).

{0}

MAR 17 1997
K961021

Summary of Safety and Effectiveness

Sponsor: Biomet, Inc.
Airport Industrial Park
P.O. Box 587
Warsaw, IN 46581-0578

Device: Kirschner® Knee Modified

Classification Name: Knee joint patellofemorotibial polymer/metal/polymer semi-constrained cemented prosthesis (CFR 888.3560).

Indications For Use: Total knee replacement is indicated for patients suffering from severe knee pain and disability. Specific indications include femoral, tibial and patellar replacement in a wide size range of patients who require implantation due to degenerative bone disease such as rheumatoid arthritis or osteoarthritis, primary and secondary traumatic arthritis, polyarthritis, collagen disorders, avascular necrosis of the femoral condyle, pseudo-gout or complications from a failed prosthesis.

Device Description: The Kirschner® Knee Modified encompasses the Kirschner Performance Total Knee System, Kirschner TC-IV Total Condylar Knee System and Kirschner HybridFit Total Knee.

Kirschner Performance Total Knee System features an anatomically designed cast cobalt chromium femoral component whose geometry allows for maximum range of motion and size interchangeability. It comes with a non-porous coated proximal supracondylar flange and two non-porous coated fixation pegs to minimize stress shielding and permit compression between the porous coated surface and bone. Five sizes in left/right anatomic configurations are available to better match the patient's anatomy. The modular titanium tibial component has four screw holes and comes with either a cruciate or round stem. Available is an all poly tibial component. There are femoral and tibial augmentations to fill cavitary defects.

Kirschner TC-IV Total Condylar Knee System features a cobalt chromium femoral component with a "waffled" non-porous coated proximal flange and two non-porous fixation pegs. The one-piece cobalt chromium tibial component has a posterior recess allowing for the retention of the posterior cruciate ligament.

The UHMWPE patellar component for both the Performance and TC-IV knee systems come in porous-coated metal-backed or all UHMWPE options.

{1}

The HybridFit cobalt chrome tibial tray accepts the TC-IV or Performance bearing inserts and can be used with either the Performance or the TC-IV femoral component.

These knee devices are intended for use with bone cement.

The major changes are in material and method of the porous coating and in the manufacturing process of the Ultra High Molecular Weight Polyethylene.

Porous coated Kirschner Knees Modified features Biomet's plasma spray coating of titanium alloy powder. The integrity of this coating has been proven in the performance of many Biomet joint prosthesis previously reviewed by the FDA. There have been no reported incidents of coating failure.

The polyethylene components are of ArCom UHMWPE, Biomet's improved polyethylene components.

Potential Risks: The potential risks associated with this device are the same as with any joint replacement device. These include, but are not limited to:

|  Reaction to bone cement | Blood vessel damage | Bone Fracture  |
| --- | --- | --- |
|  Deformity of the joint | Soft tissue imbalance | Infection  |
|  Cardiovascular disorders | Delayed wound healing | Hematoma  |
|  Fracture of the cement | Metal sensitivity | Dislocation  |
|  Implant loosening/migration | Tissue growth failure | Excessive wear  |
|  Fracture of the components | Nerve damage |   |

Substantial Equivalence: In function and overall design, Biomet's Kirschner Knee Modified knee components are equivalent to almost any knee components on the market, including:

Maxim Total Knee System (Biomet, Inc.) 510(k)# K915132 cleared for market 2/11/92.

AGC 2000 Total Knee Prosthesis (Biomet, Inc.) 510(k)# K833921 cleared for market 1/31/84.

---

**Source:** [https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/JWH/K961021](https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/JWH/K961021)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com